About Us
Pharma Inventor Inc. is a Canadian contract research organization founded on the core idea of providing inventive and cost-effective solutions to chemistry problems in drug discovery research and development areas. We are fully functional with a state-of-the-art chemistry facility and an exceptionally skilled team of global scientists to provide chemistry services in various capacities. We are here to assist our clients in pharmaceutical, biotech, agrochemical and university settings to expedite their research and development projects with innovative chemistry solutions.
MEET OUR SCIENTISTS
Anupama Patel, Ph.D.
President & Chief Executive Officer
Dr Patel founded PHARMA Inventor Inc. to fulfil her passion, capabilities and the desire to assist pharmaceutical & biotechnology companies around the globe to accelerate their discovery research programs in a cost-effective manner. She is a determined scientist who is aware of the challenges associated with establishing and growing PHARMA Inventor Inc.’s reputation in the pharmaceutical and biotechnology sectors. Dr Patel strongly believes in instilling core values of quality, reliability & integrity in PHARMA Inventor Inc.
Prior to establishing PHARMA Inventor Inc., Dr Anupama Patel was part of a dynamic research team at Albany Molecular Research Inc. in Singapore (www.amriglobal.com). Her detailed oriented and efficient project management skills were well appreciated within the organization. As a medicinal/synthetic organic chemist, she worked in multiple research projects from global pharmaceutical clients in various therapeutic areas (diabetes, cancer, bacterial infections agrochemical products).
Dr Patel obtained her doctorate degree in organic chemistry under the generous and inspiring supervision of Professor Dr Thisbe Lindhorst (www.scholle.oc.uni-kiel.de/lind).
Dr Patel was awarded a research fellowship by the German Federal Ministry of Education and Research (BMBF) to conduct her doctoral research work in the area of glycocalyx mimetics as potential therapeutic agents to treat microbial infections. Her research accomplishments are published in international peer-reviewed journals and presentations were made at various international conferences.
Prior to joining pharmaceutical industry, Dr Patel worked as a postdoctoral research fellow at the University of British Columbia, Canada under the joint supervision of Dr Stephen Withers & Dr David Perrin making key contributions to Canadian proteomics research programs (www.chem.ubc.ca).
Kashinath Sadalapure, Ph.D.
Chief Scientific Officer
Dr. Sadalapure received his Ph.D. degree in synthetic organic chemistry from the Indian Institute of Chemical Technology (IICT-Hyderabad). He went to Hamburg University (Germany) & Simon Fraser University (Vancouver, Canada) for postdoctoral research works to further understand the interactions of natural products/synthetic bio-active molecules with those that support and sustain human life (enzymes, transporters, receptors).
He has been associated with pharmaceutical industry for over 15 years and he has worked for a few Canadian pharmaceutical companies (Xenon Pharmaceuticals Inc., NAEJA Pharmaceuticals, Phyton Biotech LLC., Methylation Sciences inc.) and American companies (Albany Molecular Research Inc.,). He has been a key person with tremendous technical and bench experience of transforming inventive molecules into medicines. In his leadership positions at these pharmaceutical companies, he has managed multiple projects, supervised, coached, and mentored several scientists in cardiovascular, neuropathic pain, metabolic, anti-infectives, inflammatory diseases, oncology and CNS therapeutic areas.
Dr. Sadalapure is a young scientist and a treasure store of enormous technical experience in medicinal chemistry, process development and customized chemical synthesis of natural or unnatural products of high therapeutic values. He has made significant contributions to the scientific community with over 40 published research articles and innovative patents.
Dr. Sadalapure is committed to offering high-quality chemistry services to biotech, pharmaceutical and University researchers worldwide while keeping the cost to a minimum.